ATE367397T1 - Infektiöser klon für menschlichen parainfluenzavirus-typ - Google Patents
Infektiöser klon für menschlichen parainfluenzavirus-typInfo
- Publication number
- ATE367397T1 ATE367397T1 AT98922118T AT98922118T ATE367397T1 AT E367397 T1 ATE367397 T1 AT E367397T1 AT 98922118 T AT98922118 T AT 98922118T AT 98922118 T AT98922118 T AT 98922118T AT E367397 T1 ATE367397 T1 AT E367397T1
- Authority
- AT
- Austria
- Prior art keywords
- hpiv
- clone
- protein
- nucleotide sequence
- genome
- Prior art date
Links
- 208000015181 infectious disease Diseases 0.000 title abstract 2
- 230000002458 infectious effect Effects 0.000 title abstract 2
- 241000712003 Human respirovirus 3 Species 0.000 abstract 13
- 239000002773 nucleotide Substances 0.000 abstract 5
- 125000003729 nucleotide group Chemical group 0.000 abstract 5
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 101001065501 Escherichia phage MS2 Lysis protein Proteins 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 102000053642 Catalytic RNA Human genes 0.000 abstract 1
- 108090000994 Catalytic RNA Proteins 0.000 abstract 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 abstract 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 abstract 1
- 101900161954 Human parainfluenza 3 virus Phosphoprotein Proteins 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 102100034574 P protein Human genes 0.000 abstract 1
- 101710181008 P protein Proteins 0.000 abstract 1
- 208000002606 Paramyxoviridae Infections Diseases 0.000 abstract 1
- 101710177166 Phosphoprotein Proteins 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 238000012258 culturing Methods 0.000 abstract 1
- 230000035772 mutation Effects 0.000 abstract 1
- 108091092562 ribozyme Proteins 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18621—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18651—Methods of production or purification of viral material
- C12N2760/18652—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4580597P | 1997-05-07 | 1997-05-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE367397T1 true ATE367397T1 (de) | 2007-08-15 |
Family
ID=21939986
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98922118T ATE367397T1 (de) | 1997-05-07 | 1998-05-06 | Infektiöser klon für menschlichen parainfluenzavirus-typ |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6248578B1 (de) |
| EP (1) | EP0981537B1 (de) |
| JP (1) | JP2002512519A (de) |
| KR (2) | KR100585946B1 (de) |
| CN (1) | CN1208340C (de) |
| AT (1) | ATE367397T1 (de) |
| AU (1) | AU736586B2 (de) |
| BR (1) | BR9809240A (de) |
| CA (1) | CA2289776C (de) |
| CY (1) | CY1107730T1 (de) |
| DE (1) | DE69838097T2 (de) |
| DK (1) | DK0981537T3 (de) |
| ES (1) | ES2289782T3 (de) |
| HK (1) | HK1025973A1 (de) |
| PT (1) | PT981537E (de) |
| WO (1) | WO1998050405A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7465574B2 (en) | 1994-09-30 | 2008-12-16 | Medimmune, Llc | Recombinant RSV virus expression systems and vaccines |
| US6830748B1 (en) | 1997-09-26 | 2004-12-14 | Medimmune Vaccines, Inc. | Recombinant RSV virus expression systems and vaccines |
| US6764685B1 (en) * | 2000-03-21 | 2004-07-20 | Medimmune Vaccines, Inc. | Recombinant parainfluenza virus expression systems and vaccines |
| CN101098958A (zh) * | 2002-02-21 | 2008-01-02 | 免疫医疗疫苗公司 | 间质肺病毒株及其在疫苗制剂中以及用作抗原性序列表达载体的用途 |
| US20100316991A1 (en) * | 2009-06-11 | 2010-12-16 | Utah State University | Human parainfluenza virus type 3 expressing the enhanced green fluorescent protein for use in high-throughput antiviral assays |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5166057A (en) | 1989-08-28 | 1992-11-24 | The Mount Sinai School Of Medicine Of The City University Of New York | Recombinant negative strand rna virus expression-systems |
| EP0702085B2 (de) | 1994-07-18 | 2010-01-13 | Conzelmann, Karl-Klaus, Prof. Dr. | Rekombinantes infektiöses nicht-in-Segmente-geteiltes, negativ-Strang-RNS-Virus |
| US5869036A (en) * | 1995-12-08 | 1999-02-09 | St. Louis University | Live attenuated vaccines based on CP45 HPIV-3 strain and method to ensure attenuation in such vaccine |
-
1998
- 1998-05-06 AT AT98922118T patent/ATE367397T1/de not_active IP Right Cessation
- 1998-05-06 EP EP98922118A patent/EP0981537B1/de not_active Expired - Lifetime
- 1998-05-06 CN CNB988048833A patent/CN1208340C/zh not_active Expired - Fee Related
- 1998-05-06 DE DE69838097T patent/DE69838097T2/de not_active Expired - Fee Related
- 1998-05-06 KR KR1019997010246A patent/KR100585946B1/ko not_active IP Right Cessation
- 1998-05-06 KR KR1020067002175A patent/KR100678818B1/ko not_active IP Right Cessation
- 1998-05-06 PT PT98922118T patent/PT981537E/pt unknown
- 1998-05-06 US US09/073,492 patent/US6248578B1/en not_active Expired - Fee Related
- 1998-05-06 DK DK98922118T patent/DK0981537T3/da active
- 1998-05-06 ES ES98922118T patent/ES2289782T3/es not_active Expired - Lifetime
- 1998-05-06 CA CA002289776A patent/CA2289776C/en not_active Expired - Fee Related
- 1998-05-06 BR BR9809240-5A patent/BR9809240A/pt not_active Application Discontinuation
- 1998-05-06 WO PCT/US1998/009270 patent/WO1998050405A1/en active IP Right Grant
- 1998-05-06 JP JP54846598A patent/JP2002512519A/ja active Pending
- 1998-05-06 AU AU74731/98A patent/AU736586B2/en not_active Ceased
-
2000
- 2000-08-21 HK HK00105223A patent/HK1025973A1/xx not_active IP Right Cessation
-
2007
- 2007-09-10 CY CY20071101163T patent/CY1107730T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0981537B1 (de) | 2007-07-18 |
| AU736586B2 (en) | 2001-08-02 |
| CA2289776C (en) | 2008-10-21 |
| US6248578B1 (en) | 2001-06-19 |
| BR9809240A (pt) | 2000-06-27 |
| CY1107730T1 (el) | 2013-04-18 |
| HK1025973A1 (en) | 2000-12-01 |
| KR100585946B1 (ko) | 2006-06-07 |
| JP2002512519A (ja) | 2002-04-23 |
| EP0981537A4 (de) | 2002-09-18 |
| WO1998050405A1 (en) | 1998-11-12 |
| CN1208340C (zh) | 2005-06-29 |
| DE69838097T2 (de) | 2008-04-10 |
| KR100678818B1 (ko) | 2007-02-07 |
| KR20060014461A (ko) | 2006-02-15 |
| DK0981537T3 (da) | 2007-11-19 |
| CA2289776A1 (en) | 1998-11-12 |
| KR20010012294A (ko) | 2001-02-15 |
| AU7473198A (en) | 1998-11-27 |
| DE69838097D1 (de) | 2007-08-30 |
| PT981537E (pt) | 2007-10-16 |
| ES2289782T3 (es) | 2008-02-01 |
| CN1255140A (zh) | 2000-05-31 |
| EP0981537A1 (de) | 2000-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Galinski et al. | RNA editing in the phosphoprotein gene of the human parainfluenza virus type 3 | |
| Fodor et al. | Rescue of influenza A virus from recombinant DNA | |
| Van Der Werf et al. | Synthesis of infectious poliovirus RNA by purified T7 RNA polymerase. | |
| Schimmel | Aminoacyl tRNA synthetases: general scheme of structure-function relationships in the polypeptides and recognition of transfer RNAs | |
| Schlender et al. | Respiratory syncytial virus (RSV) fusion protein subunit F2, not attachment protein G, determines the specificity of RSV infection | |
| CA2409432A1 (en) | Modified morbillivirus v proteins | |
| Meyer et al. | The nucleotide sequence of the fusion protein gene of the peste des petits ruminants virus: the long untranslated region in the 5′-end of the F-protein gene of morbilliviruses seems to be specific to each virus | |
| Murphy et al. | A functional antigenomic promoter for the paramyxovirus simian virus 5 requires proper spacing between an essential internal segment and the 3′ terminus | |
| Barrett et al. | Nucleotide sequence of the entire protein coding region of canine distemper virus polymerase-associated (P) protein mRNA | |
| ATE417927T1 (de) | Neue knochenmineralisierungsproteine, dna, vektoren, expressionssysteme | |
| JP2004513616A5 (de) | ||
| Murphy et al. | RNA replication for the paramyxovirus simian virus 5 requires an internal repeated (CGNNNN) sequence motif | |
| NZ502391A (en) | Mammalian cytokine: interleukin-B30 and related reagents | |
| JP2007502623A (ja) | 膜タンパク質におけるフリンプロテアーゼ開裂部位の挿入およびその使用法 | |
| CN101517079A (zh) | 非复制型副粘病毒科病毒载体 | |
| DE69534600D1 (de) | Nukleotid- und aminosäuresequenzen der gene des hüllproteins 1 und des kernproteins von hepatitis c virus | |
| ID27206A (id) | Generasi produk-produk perbanyakan gena dari protein-protein fusi simerik melalui pemutusan endoprotease ubikuitus | |
| CY1107730T1 (el) | Μολυσματικος κλωνος για ιο ανθρωπινης παραγριππης τυπου 3 | |
| Leyrer et al. | Rapid and efficient recovery of Sendai virus from cDNA: factors influencing recombinant virus rescue | |
| CA2333313A1 (en) | Novel methods for rescue of rna viruses | |
| Murakami et al. | High-level expression of exogenous genes by replication-competent retrovirus vectors with an internal ribosomal entry site | |
| WO1996021020A3 (en) | Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases | |
| Hong et al. | Membrane orientation of rat gp110 as studied by in vitro translation. | |
| KR100553154B1 (ko) | Ｈｉｖ 뉴클레오캡시드 단백질의 동물세포 발현용 벡터 및 이의 제조방법 | |
| WO2002074960A3 (en) | 38650, 28472, 5495, 65507, 81588 and 14354 methods and compositions of human proteins and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0981537 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |